Investigation of microbial community structure, diversity patterns, and functional characteristics influencing compatibility between microbiome donors and recipients. Development of computational approaches for improved matching.
Pioneering the future of the microbiome.
At Bactera, we are not only working to bring innovative microbiome solutions into clinical practice! We are also committed to everyday research to help advance science. Our work bridges biotechnology, microbiology, and personalized medicine, with the goal of developing new tools to support gut health, fight disease, and improve the lives of patients.
Our scientific principles.
Scientific Rigor
Our work is based on established microbiological methods, high-resolution sequencing technologies, and peer-reviewed scientific literature. Analytical pipelines and data interpretation follow standardized bioinformatic and statistical approaches to ensure reproducibility and scientific validity.
Regulatory & Ethical Responsibility
Research involving human biological material requires strict adherence to regulatory and ethical frameworks. Bactera operates in alignment with applicable European and German regulations governing biological sample handling, data protection, and laboratory quality standards.
Scientific Collaboration
Advancement in microbiome science requires interdisciplinary collaboration. We work with researchers, clinicians, and institutions interested in microbiome biology, bacteriophages, and microbial ecosystem research.
Our research focus area.
Our research is centered on two primary pillars: I. Microbiome Analysis & Restoration, and II. Bacteriophage-Based Modulation.
I. Microbiome Analysis & Restoration
We study the human gut microbiome as a functional ecosystem and develop strategies for its precise restoration and modulation.
Donor–recipient compatibility modeling
Microbiome recovery after ecosystem disruption
Analysis of microbiome dynamics following disturbances such as antibiotic exposure, infections, or dietary shifts. Investigation of factors influencing microbiome resilience, recovery trajectories, and ecosystem stability.
Host–microbiome immune interaction
Investigation of interactions between microbial communities and host immune pathways. Characterization of microbial ecosystem features associated with immune regulation and inflammatory responses.
Gut–brain signaling pathways
Investigation of microbiome-associated metabolites and signaling molecules involved in gut–brain communication. Analysis of microbial ecosystem patterns associated with neurological and behavioral processes.
II. Bacteriophage-Based Modulation
Targeted microbial population control using bacteriophages.
Phage discovery & characterization
Isolation and characterization of bacteriophages from diverse microbial environments. Analysis of phage genomic structure, host specificity, and ecological roles within microbial ecosystems.
Targeted removal of pathogenic strains
Investigation of bacteriophage-mediated targeting of specific bacterial populations within complex microbiome communities. Evaluation of selective microbial population control strategies.
Adaptive phage evolution strategies
Study of bacteriophage evolutionary dynamics in response to bacterial resistance and environmental pressures. Analysis of mechanisms influencing phage adaptability.
Phage–microbiome ecosystem interactions
Investigation of bacteriophage influence on microbial community structure and ecosystem dynamics. Analysis of phage-driven shifts in microbiome stability and population balance.
Collaborations & Partnerships.
Who we work with.
- Universities and research institutions
- Biotech and pharmaceutical companies
- Medical clinics and healthcare providers
- International research groups
Strategic alignment.
We are aligning our development roadmap with major European scientific funding programs, including the upcoming Horizon Europe 2028–2034 framework, and plan to participate in multi-partner consortia focused on microbiome medicine, infectious disease, bacteriophages and antimicrobial resistance.
Horizon Europe 2028–2034: Actively seeking consortium partnerships for upcoming framework programs.